Profiling GABA(A) Receptor Subunit Expression in the Hippocampus of PMDD Rat Models Based on TCM Theories
- PMID: 37103685
- DOI: 10.1007/s12035-023-03354-3
Profiling GABA(A) Receptor Subunit Expression in the Hippocampus of PMDD Rat Models Based on TCM Theories
Abstract
γ-Aminobutyric acid type A receptors (GABAARs) play an important role in cognitive and emotional regulation and are related to the hippocampus. However, little is known regarding patterns of hippocampal GABAAR subunit expression in rat models of premenstrual dysphoric disorder (PMDD). This study investigated the above changes by establishing two PMDD rat models based on Traditional Chinese Medicine (TCM) theories, namely, PMDD liver-qi invasion syndrome (PMDD-LIS) and PMDD liver-qi depression syndrome (PMDD-LDS). Behavioral tests were used to detect depression and irritability emotion. Western blot analysis was used to investigate protein levels of GABAAR α1, α2, α4, α5, β2, β3, and δ subunits, whereas ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) analysis was performed to determine gamma-aminobutyric acid (GABA) and glutamate (Glu) levels in the hippocampus across each group. Concurrently, behavioral data indicated that the PMDD-LDS and PMDD-LIS rat models had been successfully established. GABAAR α2, α5, β2, and δ subunit was significantly upregulated, whereas α4 was significantly downregulated (P < 0.05) in PMDD-LDS rat models relative to controls. On the other hand, GABAAR α1, α2, and β3 were significantly downregulated while α4 and β2 were significantly upregulated in PMDD-LIS rat models relative to the control group (P < 0.05). Moreover, GABA levels significantly decreased, while Glu and the ratio of glutamate to GABA increased in PMDD-LIS rat models (P < 0.05). Conversely, GABA and Glu levels significantly decreased, whereas the ratio of glutamate to GABA increased in PMDD-LIS rat models (P < 0.05). Conclusively, our results revealed differential expression of GABAAR α1, α2, α4, α5, β2, β3, and δ subunits between PMDD-LIS and PMDD-LDS rat models, suggesting that they may be biomarkers in the pathogenesis of PMDD.
Keywords: Depression; GABAA receptor; Premenstrual dysphoric disorder; Rat model; TCM theories.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Allopregnanolone-mediated GABAA-Rα4 function in amygdala and hippocampus of PMDD liver qi-invasion syndrome model rats.Aging (Albany NY). 2023 Feb 23;15(4):1143-1157. doi: 10.18632/aging.204541. Epub 2023 Feb 23. Aging (Albany NY). 2023. PMID: 36842096 Free PMC article.
-
ShuYu capsule alleviates emotional and physical symptoms of premenstrual dysphoric disorder: Impact on ALLO decline and GABAA receptor δ subunit in the PAG area.Phytomedicine. 2024 Jul 25;130:155549. doi: 10.1016/j.phymed.2024.155549. Epub 2024 Mar 19. Phytomedicine. 2024. PMID: 38810551
-
GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain.Neuroscience. 2000;101(4):815-50. doi: 10.1016/s0306-4522(00)00442-5. Neuroscience. 2000. PMID: 11113332
-
Effects of GABA active steroids in the female brain with a focus on the premenstrual dysphoric disorder.J Neuroendocrinol. 2018 Feb;30(2). doi: 10.1111/jne.12553. J Neuroendocrinol. 2018. PMID: 29072794 Review.
-
Allopregnanolone and mood disorders.Prog Neurobiol. 2014 Feb;113:88-94. doi: 10.1016/j.pneurobio.2013.07.005. Epub 2013 Aug 23. Prog Neurobiol. 2014. PMID: 23978486 Review.
Cited by
-
The potential role of the orexin system in premenstrual syndrome.Front Endocrinol (Lausanne). 2024 Jan 16;14:1266806. doi: 10.3389/fendo.2023.1266806. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38292774 Free PMC article. Review.
-
Therapeutic potential of rutin in premenstrual depression: evidence from in vivo and in vitro studies.Front Pharmacol. 2025 Jan 14;15:1525753. doi: 10.3389/fphar.2024.1525753. eCollection 2024. Front Pharmacol. 2025. PMID: 39877393 Free PMC article.
References
-
- Mishra, S. and R. Marwaha, Premenstrual dysphoric disorder, in StatPearls. 2020: Treasure Island (FL).
-
- Halbreich U et al (2003) The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 28(Suppl 3):1–23 - PubMed
-
- Ko CH et al (2013) Depression, irritability, and anxiety in women with premenstrual dysphoric disorder. Int J Psychiatry Med 46(1):39–55 - PubMed
-
- Eisenlohr-Moul TA et al. (2019) Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change. Psychol Med 1–9
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical